Search - tctmd.com

Displaying 21 - 40 of 261

Sort: Relevancy | Date

News Daily News

多支血管病变的非糖尿病患者中 CABG 的生存优势强于 PCI

L.A. McKeown

June 29, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

Presentation

Impact of Post-Implant Asymmetry, Expansion, and Eccentricity of BVS and Metallic EES on Outcomes

Presenter: P. Suwannasom

June 03, 2016

News Daily News

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Yael L. Maxwell

May 13, 2016

News Daily News

Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG

Yael L. Maxwell

May 13, 2016

News Daily News

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Yael L. Maxwell

May 13, 2016

News Daily News

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Michael O'Riordan

April 25, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

News Daily News

在出血风险高的患者中新一代 DES 加简化 DAPT 优于 BMS

L.A. McKeown

March 08, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

L.A. McKeown

March 08, 2016

News Daily News

女性报告 PCI 术后持续心绞痛多于男性，引发更多问题

L.A. McKeown

March 06, 2016

News Daily News

Women More Often Than Men Report Lingering Angina After PCI, Raising More Questions

L.A. McKeown

March 06, 2016

News Daily News

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Michael O'Riordan

February 23, 2016

News Daily News

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Michael O'Riordan

February 23, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Daily News

5 年时 SORT OUT IV：已证实第二代支架的长期安全性更佳

L.A. McKeown

February 16, 2016

Presentation

Safety and Efficacy of EES vs SES: 5-Year Results from SORT OUT IV

Presenter: Okkels Jensen

February 15, 2016

Advertisement

多支血管病变的非糖尿病患者中 CABG 的生存优势强于 PCI

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

Impact of Post-Implant Asymmetry, Expansion, and Eccentricity of BVS and Metallic EES on Outcomes

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

在出血风险高的患者中新一代 DES 加简化 DAPT 优于 BMS

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

女性报告 PCI 术后持续心绞痛多于男性，引发更多问题

Women More Often Than Men Report Lingering Angina After PCI, Raising More Questions

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

5 年时 SORT OUT IV：已证实第二代支架的长期安全性更佳

Safety and Efficacy of EES vs SES: 5-Year Results from SORT OUT IV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content